Trauma-Associated bleeding: Management of massive transfusion

Current Opinion in Anaesthesiology

Volumn 29, Issue 2, 2016, Pages 250-255

  Stephens, Christopher T ^a   Gumbert, Sam ^a   Holcomb, John B ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Center for Translational Injury Research   (United States)

Author keywords

damage control resuscitation; hemostatic adjuncts; hemostatic resuscitation; massive transfusion protocol; viscoelastic assays

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; FIBRINOGEN CONCENTRATE; OXYGEN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; CIRCULATION; CLINICAL PROTOCOL; EMERGENCY CARE; HEALTH CARE UTILIZATION; HEMOSTASIS; HUMAN; INJURY; LABORATORY TEST; MULTICENTER STUDY (TOPIC); POINT OF CARE TESTING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; THROMBOCYTE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD COMPONENT THERAPY; COMPLICATION; HEMORRHAGE; INJURY SCALE; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; TRENDS; UNITED STATES; WOUNDS AND INJURIES;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD COMPONENT TRANSFUSION; CLINICAL PROTOCOLS; HEMORRHAGE; HEMOSTASIS; HUMANS; INJURY SEVERITY SCORE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; WOUNDS AND INJURIES;

EID: 84961254702     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000306     Document Type: Review

References (42)

1. Norton R, Kobusingye O. Injuries. N Engl J Med 2013; 368:1723-1730.
2. National Center for Injury Prevention and Control. CDC Injury Research Agenda, 2009-2018. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2009.
3. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008; 65:748-754.
4. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62:307-310.
5. Simmons JW, Pittet JF, Pierce B. Trauma-induced coagulopathy. Curr Anesthesiol Rep 2014; 4:189-199.
6. Cohen MJ. Acute traumatic coagulopathy: clinical characterization and mechanistic investigation. Thromb Res 2014; 133:S25-S27.
7. Holcomb JB, Donathan DP, Cotton BA, et al. Prehospital transfusion of plasma and red blood cells in trauma patients. Prehosp Emerg Care 2015; 19:1-9.
8. Del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75:S24-S30.
9. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-458.
10. Reynolds PS, Michael MJ, Cochran ED, et al. Prehospital use of plasma in traumatic hemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial. Trials 2015; 16:321.
11. Nunez TC, Young PP, Holcomb JB, Cotton BA. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010; 68:1498-1505.
12. Shaz BH, Dante CJ, Harris FIS, et al. Transfusion management of trauma patients. Anesth Analg 2009; 108:1760-1768.
13. Morse BC, Dente CJ, Hodgman EL, et al. Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. Am Surg 2012; 78:679-684.
14. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009; 66:1616-1624.
15. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-1182.
16. Cotton BA, Dossett LA, Haut ER, et al. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma 2010; 69:S33-S39.
17. Pommerening MJ, Goodman MD, Holcomb JB, et al., MPH on behalf of the PROMMTT Study Group. Clinical gestalt and the prediction of massive transfusion after trauma. Injury 2015; 46:807-813.
18. Riskin D. Massive transfusion protocols: The role of aggressive resuscitation versus product ratio inmortality reduction. JAmColl Surg2009;209:198-205.
19. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs. A 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial. JAMA 2015; 313:483-494.
20. Brown JB, Cohen MJ, Minei JP, et al. Debunking the survival bias myth: characterization of mortality during the initial 24 h for patients requiring massive transfusion. J Trauma Acute Care Surg 2012; 73:358-364.
21. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: A randomized feasibility trial. CMAJ 2013; 185:E583-E589.
22. Shrestha B, Holcomb JB, Camp EA, et al. Damage-control resuscitation increases successful nonoperative management rates and survival after severe blunt liver injury. J Trauma Acute Care Surg 2015; 78:336-341.
23. Johansson PI, Stensballe J, Oliveri R, et al. How I treat patients with massive hemorrhage. Blood 2014; 124:3052-3058.
24. Maciel JD, Gifford E, Plurad D, et al. The impact of a massive transfusion protocol on outcomes among patients with abdominal aortic injuries. Ann Vasc Surg 2015; 29:764-769.
25. Johansson PI. Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 2012; 25:235-241.
26. Cirocchi R, Abraha I, Montedori A, et al. Damage control surgery for abdominal trauma. Cochrane Database Syst Rev 2010; CD007438.
27. Holcomb JB, Spinella PC. Optimal use of blood in trauma patients. Biologicals 2010; 38:72-77.
28. Cotton BA, Reddy N, Hatch QM, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254:598-605.
29. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thromboelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256:476-486.
30. Abdelfattah K, Cripps M. Thromboelastography and rotational thromboelastometry use in trauma. Intl J Surg 2015.
31. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thromboelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256:476-486.
32. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376:23-32.
33. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147:113-119.
34. Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: A prospective cohort study. Ann Surg 2015; 261:390-394.
35. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15:R83.
36. Aubron C, Reade MC, Fraser JF, Cooper DJ. Efficacy and safety of fibrinogen concentrate in trauma patients: A systematic review. J Crit Care 2014; 29:471e11-471e17.
37. Ansell J, Hirsh J, Hylek E, et al., Palareti GAmerican College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 1332008; 160-198S (Suppl 6).
38. Matsushima K, Benjamin E, Demetriades D. Prothrombin complex concentrate in trauma patients. Am J Surg 2015; 209:413-417.
39. Grottke O, Levy JH. Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology 2015; 122:923-931.
40. Hauser CJ, Boffard K, Dutton R, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69:489-500.
41. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59:8-15.
42. Stanworth SJ, Birchall J, Doree W, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2007; (2):CD005011.